2022
DOI: 10.1016/j.ijpharm.2022.122057
|View full text |Cite
|
Sign up to set email alerts
|

Direct detection of the crystal form of an active pharmaceutical ingredient in tablets by X-ray absorption fine structure spectroscopy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 39 publications
0
12
0
Order By: Relevance
“…Radiation damages were presumed to be negligible, because the coloring of the samples after the measurements were unrecognizable by the visual inspection and because the damages of the APIs at this synchrotron facility were shown to be little by the facts that the repeated measurements on same samples gave same XANES spectra. 10,13,14) ATHENA 16) was used to process the XANES spectra; the background was subtracted and the spectra were normalized so that the sharp increase at the edge was 1.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Radiation damages were presumed to be negligible, because the coloring of the samples after the measurements were unrecognizable by the visual inspection and because the damages of the APIs at this synchrotron facility were shown to be little by the facts that the repeated measurements on same samples gave same XANES spectra. 10,13,14) ATHENA 16) was used to process the XANES spectra; the background was subtracted and the spectra were normalized so that the sharp increase at the edge was 1.…”
Section: Methodsmentioning
confidence: 99%
“…XANES spectroscopy is the method with a high element specificity and is suitable for detecting specifically the interatomic interactions at the X-ray absorbing atoms. The typical target elements of XANES spectroscopy in pharmaceutical research are chlorine, [9][10][11] bromine 12,13) and phosphorus, 14) although XANES may be applied, in principle, to all elements.…”
Section: Introductionmentioning
confidence: 99%
“…If at least one of the coformers is an active pharmaceutical ingredients (APIs) and the other is pharmaceutically acceptable in cocrystals, then it is recognized as a pharmaceutical cocrystal. [4][5][6] Pharmaceutical cocrystals have taken the limelight of interest because they can improve the physicochemical properties of APIs such as solubility, stability, bioavailability without changing the chemical integrity of the drugs. [7,8] Studies have been reported improvements in dissolution rate by Rodríguez-Hornedo et al [9], stability by Liu et al [10] and bioavailability by Nangia et al [11] .…”
Section: Introductionmentioning
confidence: 99%
“…16 Recently, we have shown that XAFS spectroscopy can be used to discriminate crystal polymorphs of bromhexine hydrochloride and also identified the polymorphs in tablets nondestructively. 18 The additives in the tablets have little influence on the shapes of XAFS spectra. This means that the method can be applied to determine the crystalline form of APIs in actual pharmaceutical formulations containing additive.…”
Section: ■ Introductionmentioning
confidence: 99%
“…Furthermore, in the case of indomethacin ASDs, the crystallization tendency of the API in the ASD had been quantitatively assessed . Recently, we have shown that XAFS spectroscopy can be used to discriminate crystal polymorphs of bromhexine hydrochloride and also identified the polymorphs in tablets nondestructively . The additives in the tablets have little influence on the shapes of XAFS spectra.…”
Section: Introductionmentioning
confidence: 99%